Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Specific inhibition of CD4+ T lymphocytes by a hybrid antibody

Nature Biotechnology volume 16, pages 271–275 (1998)Cite this article

Abstract

T lymphocytes are crucial in the defense against foreign intruders and cancerous growths. Yet, in circumstances such as transplantation or autoimmunity, T-cell–mediated responses can be detrimental. Inhibition of these deleterious responses is currently achieved by drugs that induce general immune suppression. These compounds also impair the patient's defenses against infections. Strategies are now being sought that induce selective rather than generalized immune unresponsiveness. One such strategy is the ability to inhibit the activation of CD8+ T lymphocytes. As CD4′ T lymphocytes similarly participate in graft rejection and in autoimmune diseases, we have now developed a reagent to delete their activity. It comprises CD4 and an anti-MHC class II antibody. By virtue of the antibody's specificity for MHC class II molecules, this hybrid antibody (Hab) binds to class II molecules, thereby bringing CD4 accessory molecules to the surface of class ll–bearing stimulator cells where they occupy CD4 binding sites on class II molecules. As a consequence CD4+ T cells with specificity to Hab-coated stimulator cells cannot engage their CD4 molecules and are no longer activated. This Hab technology provides a strategy to offer specific rather than generalized immune suppression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Miller, R.G. 1980. An immunological suppressor cell inactivating cytotoxic T lymphocyte precursor cells recognizing it. Nature 287: 544–546

    Article  CAS  Google Scholar 

  2. Rammensee, H.-G., Nagy, Z.A. and Klein, J. 1982. Suppression of cell-mediated lymphotoxicity against minor histocompatibility antigens mediated by Ly 1+ Ly 2+ T cells of stimulator strain origin. Eur. J. Immunol. 12: 930–934

    Article  CAS  Google Scholar 

  3. Fink, P.J., Weissman, I.L. and Bevan, M.J. 1983. Haplotype specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells . J. Exp.Med. 157: 141–154

    Article  CAS  Google Scholar 

  4. Hambar, J.E., Kaplan, D.R. and Tykocinski, M.L. 1990. CD8 functions as inhibitory ligand in mediating the immunoregulaory activity of CD8+ cells. J. Immunol. 12: 930–934

    Google Scholar 

  5. Sambhara, S., and Miller, R.G. 1991. Programmed cell death of T cells signaled by theTcell receptor and the α, domain of class I MHC. Science. 252:1424–1427

    Article  CAS  Google Scholar 

  6. Rammensee, H.-G. 1989. Veto function in vitro and in vivo. Int. Rev. Immunol. 4: 175–191

    Article  CAS  Google Scholar 

  7. Martin, D.R., and Milter, R.G. 1989. In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors. J. Exp. Med. 170: 679–690

    Article  CAS  Google Scholar 

  8. Rammensee, H.-G., Juretic, A., Nagy, Z.A., and Klein, J. 1984. Class l-restricted interaction between suppressor and cytolytic cells in the response to minor histocompatibility antigens. J. Immunol. 132: 668–672

    CAS  Google Scholar 

  9. Zhang, L., Shannon, J., Sheldon, J., Teh, H.-S., Mak, T.W. and Miller, R.G. 1994. Role of infused CD8- cells in the induction of peripheral tolerance. J. Immunol. 152: 2221–2228

    Google Scholar 

  10. Johnson, L.L. 1987. Prolonged minor allograft survival of intravenously primed mice-a test of the veto hypothesis. Transplantation 44: 92–97

    Article  CAS  Google Scholar 

  11. Thomas, J.M., Carver, F.M., Cunningham, P.R., Oison, L.C., and Thomas, F.T. 1991. Kidney allograft tolerance in primates without chronic immunosuppression. Transplant. Proc. 23: 11–13

    CAS  PubMed  Google Scholar 

  12. Takahashi, T., and Maki, H. 1991. Prolongation of mouse skin allograft survival by cloned veto suppressor cells. Transplant. Proc. 23: 192–193

    CAS  PubMed  Google Scholar 

  13. Hiruma, K., Nakamura, H., Henkart, P.A. and Gress, R.E. 1992. Clonal deletion of postthymic T cells: Veto cells kill precursor cytotoxic T lymphocytes. J. Exp. Med. 175: 863–868

    Article  CAS  Google Scholar 

  14. Thomas, J.M., Carver, P.M., Kasten-Jolly, J., Haisch, C.E., Rebellato, L.M., Gross, U. et al. 1994. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation. 57: 101–115.

    Article  CAS  Google Scholar 

  15. Rotzschke, O., Falk, K., Faath, S. and Rammensee, H.-G. 1991. On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174: 1059–1071.

    Article  CAS  Google Scholar 

  16. Matis LA., Sorger, S.B., McElligott, D.L., Fink, RJ and Hedrick, S.M. 1987. The molecular basis of alloreactivity in antigen-specific, major histocompatibility complex-restricted T cell clones. Cell 51: 59–69.

    Article  CAS  Google Scholar 

  17. Liu, Z., Sun, Y.K., Xi, Y.P., Maffei, A., Reed, E., Harris, P. et al. 1994. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J. Exp. Med. 177: 1643–1650

    Article  Google Scholar 

  18. Fangmann, J., Dalchau, R. and Fabre, J.W. 1992. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex pep-tides. J. Exp. Med. 175: 1521–1529

    Article  CAS  Google Scholar 

  19. Hambor, J.E., Weber, M.C., Tykocinski, M.L. and Kaplan, D.R. 1990. Regulation of allogeneic responses by expression of CD8 α-chain on stimulator cells. Intern. Immunol. 2: 879–883.

    Article  CAS  Google Scholar 

  20. Rosenberg, A.S. and Singer, A. 1992. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu. Rev. Immunol. 10: 333–358

    Article  CAS  Google Scholar 

  21. Cobbold, S. and Waldmann, H. 1986. Skin allograft rejection by L3T4+ and Lyt-2+ T cell subsets. Transplantation 41: 634–639

    Article  CAS  Google Scholar 

  22. Mizuochi, T., Goldlng, H., Rosenberg, A.S., Glimcher, L.H., Malek, T.R. and Singer, A. 1985. Both L3T4+ and Lyt-2+ T cells initiate cytotoxic T lymphocyte responses against allogeneic major histocompatibility antigens but not against trinitrophenyl-modified self. J. Exp. Med. 162: 427–143

    Article  CAS  Google Scholar 

  23. Nepom, G.T. and Erlich, H. 1991. MHC class-ll molecules and autoimmunity.Annu. Rev. Immunol. 9: 493–525

    Article  CAS  Google Scholar 

  24. O'Garra, A. and Murphy, K. T-cell subsets in autoimmunity. Curr. Opinion Immuno. 5: 880–886 1993.

    Article  CAS  Google Scholar 

  25. Qi, Y., Berg, R., Singleton, M.A., Debrick, J.E. and Staerz, U.D. 1996. Hybrid antibody mediated veto of cytotoxic T lymphocyte responses. J. Exp. Med. 183: 1973–1980

    Article  CAS  Google Scholar 

  26. Staerz, U.D., Kanagawa, O. and Bevan, M.J. 1983. Hybrid antibodies can target sites for attack by T cells. Nature 314: 628–631

    Article  Google Scholar 

  27. Staerz, U.D. and Bevan, M.J. 1986. Hybrid hybridoma producing a bispecific monoclonal antibody which can focus T cell activity. Proc. Natl. Acad. Sci. USA 83: 1453–1457

    Article  CAS  Google Scholar 

  28. Staerz, U.D., Yewdell, J.W. and Bevan, M.J. 1987.Hybrid antibody mediated lysis of virus infected cells. Eur. J. Immunol. 17: 571–574

    Article  CAS  Google Scholar 

  29. Zepp, F. and Staerz, U.D. 1988. Hybrid antibodies induce selection processes in the thymus. Nature 336: 473–475

    Article  CAS  Google Scholar 

  30. Traunecker, A., Lueke, W. and Karjalainen, K. 1988. Soluble CD4 molecules neutralize human immunodeficiency virus type I. Nature 331: 84–86

    Article  CAS  Google Scholar 

  31. Ozato, K., Mayer, N. and Sachs, D.H. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H–2 and la antigens. J. Immunol. 124: 533–540.

    CAS  Google Scholar 

  32. Mosmann, T.R. and Coffman, R.L. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.Annu. Rev. Immunol. 7: 145–179.

    Article  CAS  Google Scholar 

  33. Smith, D.M., Bluestone, J.A., Newberg, M.K., Englehard, V.H., Thistlethwaite, J.R., and Woode, E.S. 1994. Inhibition of T cell activity by a monoclonal antibody directed against the alpha 3 domain of the Class I MHC molecule. J. Immunol. 153: 1054–1067.

    CAS  PubMed  Google Scholar 

  34. Sprent, J. and Schaefer, M. 1990. Antigen-presenting cells for CD8+ T cells. [Review]. Immunol. Rev. 117: 213–234.

    Article  CAS  Google Scholar 

  35. Kosaka, H., Surh, C.D. and Sprent, J. 1992. Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen-presenting cells in vivo. J. Exp. Med. 176: 1291–1302.

    Article  CAS  Google Scholar 

  36. Murphy, K.M., Heimberger, A.B. and Loh, D.Y. 1990. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250: 1720–1722.

    Article  CAS  Google Scholar 

  37. Liu, C.P., Kappler, J.W. and Marrack, P. 1996. Thymocytes can become mature T cells without passing through the CD4+CD8+, double positive stage. J. Exp. Med. 184: 1619–1630

    Article  CAS  Google Scholar 

  38. Steinman, R.M., Kaplan, G., Witmer, M.D. and Conn, Z.A. 1979. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J. Exp. Med. 149:1–16.

    Article  CAS  Google Scholar 

  39. Vella, A., Teague, T.K., Ihle, J., Kappler, J.W. and Marrack, R. 1997. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: State is probably not required for the effect of IL-4. J. Exp. Med. 186:325–330.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Uwe D. Staerz: (e-mail: staerzu@njc.org).

Authors and Affiliations

  1. Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO, 80206

    Yan Qi

  2. Department of Immunology, University of Colorado Health Sciences Center, Denver, CO, 80220

    Uwe D. Staerz

  3. The Cancer Center, University of Colorado Health Sciences Center, Denver, CO, 80220

    Uwe D. Staerz

Authors
  1. Yan Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Uwe D. Staerz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qi, Y., Staerz, U. Specific inhibition of CD4+ T lymphocytes by a hybrid antibody. Nat Biotechnol 16, 271–275 (1998). https://doi.org/10.1038/nbt0398-271

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0398-271

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing